Discounted Cash Flow Rating

Strong Buy

Return on Equity Rating

Strong Sell

Debt to Equity Rating

Sell

Price to Earnings Rating

Sell

Analyst Rating

Neutral

Simple Moving Average

Neutral

Exponential Moving Average

Neutral

Relative Strength Index

Standard Deviation

Strong Sell

Williams %R

Strong Buy

Average Directional Index

Strong Sell

Insider Trading

Strong Buy

Wall Street Data Solutions Rating

Neutral

B

Catalyst Biosciences, Inc. (CBIO)

Pharmaceutical Preparations

https://www.catalystbiosciences.com

Catalyst Biosciences Inc is a clinical-stage biopharmaceutical company. It mainly focuses on developing novel medicines to address serious medical conditions for individuals in need of treatment options. The company emphasizes product development efforts in the field of hemostasis and to develop valuable therapies for individuals with hemophilia. It is engaged in the clinical development of improved, next-generation subcutaneous prophylaxis using enhanced potency Factor VIIa and Factor IX variants.

611 GATEWAY BLVD., SUITE 710
SOUTH SAN FRANCISCO, CA

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

04/12/2006

Market Cap

19,418,203

Shares Outstanding

37,980,000

Weighted SO

37,978,142

Total Employees

N/A

Upcoming Earnings

04/04/2024

Similar Tickers

HTGM --.--%

BLPH --.--%

BLPH --.--%

AKTX --.--%

AKTX --.--%

BNTC --.--%

BNTC --.--%

PULM --.--%

PULM --.--%

Beta

1.2900

Last Div

15.9400

Range

0.1887-8.693999

Chg

-0.0139

Avg Vol

437269

Mkt Cap

19418203

Exch

NASDAQ

Country

US

Phone

650 871 0761

DCF Diff

1.4473

DCF

3.3873

Div Yield

0.0000

P/S

-24.4562

EV Multiple

-0.4760

P/FV

0.5386

Div Yield %

0.0000

P/E

-0.4389

PEG

-0.0048

Payout

-0.2885

Current Ratio

0.0000

Quick Ratio

0.0000

Cash Ratio

0.0000

DSO

0.0000

DIO

0.0000

Op Cycle

0.0000

DPO

0.0000

CCC

0.0000

Gross Margin

3.1461

Op Margin

55.7456

Pretax Margin

55.2620

Net Margin

55.7204

Eff Tax Rate

-0.0083

ROA

-0.7091

ROE

12.0409

ROCE

-0.7094

NI/EBT

1.0083

EBT/EBIT

0.9913

EBIT/Rev

55.7456

Debt Ratio

0.0000

D/E

0.0000

LT Debt/Cap

0.0000

Total Debt/Cap

0.0000

Int Coverage

-71.3903

CF/Debt

0.0000

Equity Multi

1.7306

Rec Turnover

0.0000

Pay Turnover

0.0000

Inv Turnover

0.0000

FA Turnover

0.0000

Asset Turnover

-0.0127

OCF/Share

-0.3523

FCF/Share

-0.3523

Cash/Share

0.0000

OCF/Sales

16.8501

FCF/OCF

1.0000

CF Coverage

0.0000

ST Coverage

0.0000

CapEx Coverage

0.0000

Div&CapEx Cov

-1.0482

P/BV

0.5386

P/B

0.5386

P/S

-24.4562

P/E

-0.4389

P/FCF

-1.4514

P/OCF

-1.4513

P/CF

-1.4513

PEG

-0.0048

P/S

-24.4562

EV Multiple

-0.4760

P/FV

0.5386

DPS

0.0000

Latest Headlines (EST)

GlobeNewswire Inc. Apr 03, 22:30 Texas Capital Bancshares, Inc. Announces Date for Q1 2025 Operating Results GlobeNewswire Inc. Jan 27, 23:05 Texas Capital Bancshares, Inc. Announces Quarterly Dividend for Preferred Stock Benzinga Jan 27, 23:05 Texas Capital Bancshares, Inc. Announces Quarterly Dividend for Preferred Stock GlobeNewswire Inc. Jan 09, 23:00 Texas Capital Bancshares, Inc. Announces Date for Full Year and Q4 2024 Operating Results GlobeNewswire Inc. Oct 30, 12:00 Catalyst Biosciences Announces Completion of Business Combination With Beijing Continent Pharmaceuticals and Implementation of Name Change and Reverse Stock Split

Revenue Product Segmentation

Dividend History

Cash Value Ex-Dividend Date Declaration Date Record Date Pay Date
0.02 01/13/2023 12/26/2022 01/05/2023 11/30/-0001
0.36 09/21/2022 08/25/2022 09/06/2022 09/20/2022
0.14 08/20/2015 08/18/2015 08/14/2015 08/19/2015